Exploring Adiponectin in Autosomal Dominant Kidney Disease: Insight and Implications
Genes · 2024
DOI: 10.3390/genes15040484 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Ersilia Nigro und 8 weiteren Autor:innen. Beteiligte Einrichtung: CEINGE-Biotecnologie Avanzate Scarl "Franco Salvatore", Via G. Salvatore 486, 80145 Naples, Italy. Hauptthemen laut MEDLINE: Adiponectin, Polycystic Kidney, Autosomal Dominant, Receptors, Adiponectin, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a common monogenic disorder characterized by renal cysts and progressive renal failure. In kidney diseases, adipose tissue undergoes functional changes that have been associated with increased inflammation and insulin resistance mediated by release of adipokines. Adiponectin is involved in various cellular processes, such as energy and inflammatory and oxidative processes. However, it remains to be determined whether adiponectin is involved in the concomitant metabolic dysfunctions present in PKD. In this scenario, we aimed to analyze: (a) PPARγ, ADIPOQ, ADIPOR1 and ADIPOR2 gene variations in 92 ADPKD patients through PCR-Sanger sequencing; and (b) adiponectin levels and its oligomerization state by ELISA and Western Blot. Our results indicated that: (a) 14 patients carried the PPARγ SNP, 29 patients carried the ADIPOQ SNP rs1501299, and 25 patients carried the analyzed ADIPOR1 SNPs. Finally, 82 patients carried ADIPOR2 SNPs; and (b) Adiponectin is statistically lower in ADPKD patients compared to controls, and further statistically lower in ESRD than in non-ESRD patients. An inverse relationship between adiponectin and albumin and between adiponectin and creatinine and a direct relationship between adiponectin and eGFR were found. Interestingly, significantly lower levels of adiponectin were found in patients bearing the ADIPOQ rs1501299 SNP and associated with low levels of eGFR. In conclusion, adiponectin levels and the presence of ADIPOQ rs1501299 genotype are significantly associated with a worse ADPKD phenotype, indicating that both could potentially provide important insights into the disease. Further studies are warranted to understand the pathophysiological role of adiponectin in ADPKD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CEINGE-Biotecnologie Avanzate Scarl "Franco Salvatore", Via G. Salvatore 486, 80145 Naples, Italy.
- Dipartimento di Scienze e Tecnologie Ambientali, Biologiche, Farmaceutiche, Università della Campania "Luigi Vanvitelli", Via Vivaldi 43, 81100 Caserta, Italy.
- Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi "Federico II", Via Pansini 5, 80131 Naples, Italy.
- Unità di Nefrologia, Dipartimento di Sanità Pubblica, Università di Napoli "Federico II", Via Pansini 5, 80131 Naples, Italy.
- Department of Clinical Medicine and Surgery, University of Naples "Federico II", Via Pansini 5, 80131 Naples, Italy.
ORCID-Profile: Marta Mallardo, Maurizio Marra, Fabrizio Pasanisi
Zitieren
APA
Nigro, E., Mallardo, M., Amicone, M., D'Arco, D., Riccio, E., Marra, M., Pasanisi, F., Pisani, A., & Daniele, A. (2024). Exploring Adiponectin in Autosomal Dominant Kidney Disease: Insight and Implications. Genes. https://doi.org/10.3390/genes15040484
Vancouver
Nigro E, Mallardo M, Amicone M, D'Arco D, Riccio E, Marra M, et al. Exploring Adiponectin in Autosomal Dominant Kidney Disease: Insight and Implications. Genes. 2024. doi:10.3390/genes15040484
BibTeX
@article{Nigro2024,
author = {Nigro, Ersilia and Mallardo, Marta and Amicone, Maria and D'Arco, Daniela and Riccio, Eleonora and Marra, Maurizio and Pasanisi, Fabrizio and Pisani, Antonio and Daniele, Aurora},
title = {Exploring Adiponectin in Autosomal Dominant Kidney Disease: Insight and Implications},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15040484}
}
EUVIMED